Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Nicotine | The risk or severity of adverse effects can be increased when Clorexolone is combined with Nicotine. |
| Mecamylamine | The risk or severity of adverse effects can be increased when Clorexolone is combined with Mecamylamine. |
| Pentolinium | The risk or severity of adverse effects can be increased when Clorexolone is combined with Pentolinium. |
| Trimethaphan | The risk or severity of adverse effects can be increased when Clorexolone is combined with Trimethaphan. |
| Hexamethonium | The risk or severity of adverse effects can be increased when Clorexolone is combined with Hexamethonium. |
| Cyclopentamine | The risk or severity of adverse effects can be increased when Clorexolone is combined with Cyclopentamine. |
| Methotrexate | The protein binding of Methotrexate can be increased when combined with Clorexolone. |
| Dexketoprofen | The risk or severity of adverse effects can be increased when Dexketoprofen is combined with Clorexolone. |
| Ketoprofen | The risk or severity of adverse effects can be increased when Ketoprofen is combined with Clorexolone. |
| Cyclosporine | The risk or severity of renal failure can be increased when Clorexolone is combined with Cyclosporine. |
| Sodium phosphate, monobasic | Clorexolone may increase the nephrotoxic activities of Sodium phosphate, monobasic. |
| Acemetacin | The therapeutic efficacy of Clorexolone can be decreased when used in combination with Acemetacin. |
| Lactulose | The risk or severity of dehydration can be increased when Clorexolone is combined with Lactulose. |
| Magnesium sulfate | The risk or severity of dehydration can be increased when Clorexolone is combined with Magnesium sulfate. |
| Mannitol | The risk or severity of dehydration can be increased when Clorexolone is combined with Mannitol. |
| Lubiprostone | The risk or severity of dehydration can be increased when Clorexolone is combined with Lubiprostone. |
| Tegaserod | The risk or severity of dehydration can be increased when Clorexolone is combined with Tegaserod. |
| Magnesium oxide | The risk or severity of dehydration can be increased when Clorexolone is combined with Magnesium oxide. |
| Magnesium cation | The risk or severity of dehydration can be increased when Clorexolone is combined with Magnesium cation. |
| Sorbitol | The risk or severity of dehydration can be increased when Clorexolone is combined with Sorbitol. |
| Dantron | The risk or severity of dehydration can be increased when Clorexolone is combined with Dantron. |
| Oxyphenisatin | The risk or severity of dehydration can be increased when Clorexolone is combined with Oxyphenisatin. |
| Phenolphthalein | The risk or severity of dehydration can be increased when Clorexolone is combined with Phenolphthalein. |
| Prucalopride | The risk or severity of dehydration can be increased when Clorexolone is combined with Prucalopride. |
| Emodin | The risk or severity of dehydration can be increased when Clorexolone is combined with Emodin. |
| Linaclotide | The risk or severity of dehydration can be increased when Clorexolone is combined with Linaclotide. |
| Bisacodyl | The risk or severity of dehydration can be increased when Clorexolone is combined with Bisacodyl. |
| Magnesium hydroxide | The risk or severity of dehydration can be increased when Clorexolone is combined with Magnesium hydroxide. |
| Bisoxatin | The risk or severity of dehydration can be increased when Clorexolone is combined with Bisoxatin. |
| Picosulfuric acid | The risk or severity of dehydration can be increased when Clorexolone is combined with Picosulfuric acid. |
| Magnesium trisilicate | The risk or severity of dehydration can be increased when Clorexolone is combined with Magnesium trisilicate. |
| Polyethylene glycol | The risk or severity of dehydration can be increased when Clorexolone is combined with Polyethylene glycol. |
| Polycarbophil | The risk or severity of dehydration can be increased when Clorexolone is combined with Polycarbophil. |
| Magnesium acetate tetrahydrate | The risk or severity of dehydration can be increased when Clorexolone is combined with Magnesium acetate tetrahydrate. |
| Monopotassium phosphate | The risk or severity of dehydration can be increased when Clorexolone is combined with Monopotassium phosphate. |
| Dipotassium phosphate | The risk or severity of dehydration can be increased when Clorexolone is combined with Dipotassium phosphate. |
| Glycerin | The risk or severity of dehydration can be increased when Clorexolone is combined with Glycerin. |
| Sodium sulfate | The risk or severity of dehydration can be increased when Clorexolone is combined with Sodium sulfate. |
| Magnesium carbonate | The risk or severity of dehydration can be increased when Clorexolone is combined with Magnesium carbonate. |
| Potassium lactate | The risk or severity of dehydration can be increased when Clorexolone is combined with Potassium lactate. |
| Sodium fluorophosphate | The risk or severity of dehydration can be increased when Clorexolone is combined with Sodium fluorophosphate. |
| Mineral oil | The risk or severity of dehydration can be increased when Clorexolone is combined with Mineral oil. |
| Carboxymethylcellulose | The risk or severity of dehydration can be increased when Clorexolone is combined with Carboxymethylcellulose. |
| Docusate | The risk or severity of dehydration can be increased when Clorexolone is combined with Docusate. |
| Plantago seed | The risk or severity of dehydration can be increased when Clorexolone is combined with Plantago seed. |
| Magnesium citrate | The risk or severity of dehydration can be increased when Clorexolone is combined with Magnesium citrate. |
| Castor oil | The risk or severity of dehydration can be increased when Clorexolone is combined with Castor oil. |
| Magnesium glycinate | The risk or severity of dehydration can be increased when Clorexolone is combined with Magnesium glycinate. |
| Methylcellulose | The risk or severity of dehydration can be increased when Clorexolone is combined with Methylcellulose. |
| Sennosides | The risk or severity of dehydration can be increased when Clorexolone is combined with Sennosides. |
| Lactitol | The risk or severity of dehydration can be increased when Clorexolone is combined with Lactitol. |
| Plecanatide | The risk or severity of dehydration can be increased when Clorexolone is combined with Plecanatide. |
| Gluconic Acid | The risk or severity of dehydration can be increased when Clorexolone is combined with Gluconic Acid. |
| Magnesium peroxide | The risk or severity of dehydration can be increased when Clorexolone is combined with Magnesium peroxide. |
| Pentaerithrityl | The risk or severity of dehydration can be increased when Clorexolone is combined with Pentaerithrityl. |
| Sodium tartrate | The risk or severity of dehydration can be increased when Clorexolone is combined with Sodium tartrate. |
| Magnesium acetate | The risk or severity of dehydration can be increased when Clorexolone is combined with Magnesium acetate. |
| Deacetylbisacodyl | The risk or severity of dehydration can be increased when Clorexolone is combined with Deacetylbisacodyl. |
| Sodium ascorbate | The risk or severity of dehydration can be increased when Clorexolone is combined with Sodium ascorbate. |
| Potassium sulfate | The risk or severity of dehydration can be increased when Clorexolone is combined with Potassium sulfate. |
| Sodium phosphate, dibasic | The risk or severity of dehydration can be increased when Clorexolone is combined with Sodium phosphate, dibasic. |
| Sodium phosphate, monobasic, unspecified form | The risk or severity of dehydration can be increased when Clorexolone is combined with Sodium phosphate, monobasic, unspecified form. |
| Sodium phosphate, dibasic, unspecified form | The risk or severity of dehydration can be increased when Clorexolone is combined with Sodium phosphate, dibasic, unspecified form. |
| Sodium cation | The risk or severity of dehydration can be increased when Clorexolone is combined with Sodium cation. |
| Plantago ovata seed | The risk or severity of dehydration can be increased when Clorexolone is combined with Plantago ovata seed. |
| Oxyphenisatin acetate | The risk or severity of dehydration can be increased when Clorexolone is combined with Oxyphenisatin acetate. |
| Calcium polycarbophil | The risk or severity of dehydration can be increased when Clorexolone is combined with Calcium polycarbophil. |
| Konjac mannan | The risk or severity of dehydration can be increased when Clorexolone is combined with Konjac mannan. |
| Alloin | The risk or severity of dehydration can be increased when Clorexolone is combined with Alloin. |
| Frangula purshiana bark | The risk or severity of dehydration can be increased when Clorexolone is combined with Frangula purshiana bark. |
| Dehydrocholic acid | The risk or severity of dehydration can be increased when Clorexolone is combined with Dehydrocholic acid. |
| Sulfate ion | The risk or severity of dehydration can be increased when Clorexolone is combined with Sulfate ion. |
| Insulin human | The risk or severity of hypoglycemia can be increased when Clorexolone is combined with Insulin human. |
| Insulin lispro | The risk or severity of hypoglycemia can be increased when Clorexolone is combined with Insulin lispro. |
| Insulin glargine | The risk or severity of hypoglycemia can be increased when Clorexolone is combined with Insulin glargine. |
| Insulin pork | The risk or severity of hypoglycemia can be increased when Clorexolone is combined with Insulin pork. |
| Troglitazone | The therapeutic efficacy of Troglitazone can be increased when used in combination with Clorexolone. |
| Glimepiride | The therapeutic efficacy of Glimepiride can be increased when used in combination with Clorexolone. |
| Sulfisoxazole | The therapeutic efficacy of Sulfisoxazole can be increased when used in combination with Clorexolone. |
| Disopyramide | The therapeutic efficacy of Disopyramide can be increased when used in combination with Clorexolone. |
| Acarbose | The therapeutic efficacy of Acarbose can be increased when used in combination with Clorexolone. |
| Metformin | The therapeutic efficacy of Metformin can be increased when used in combination with Clorexolone. |
| Sulfadiazine | The therapeutic efficacy of Sulfadiazine can be increased when used in combination with Clorexolone. |
| Rosiglitazone | The therapeutic efficacy of Rosiglitazone can be increased when used in combination with Clorexolone. |
| Acetohexamide | The therapeutic efficacy of Acetohexamide can be increased when used in combination with Clorexolone. |
| Quinine | The therapeutic efficacy of Quinine can be increased when used in combination with Clorexolone. |
| Miglitol | The therapeutic efficacy of Miglitol can be increased when used in combination with Clorexolone. |
| Chlorpropamide | The therapeutic efficacy of Chlorpropamide can be increased when used in combination with Clorexolone. |
| Nateglinide | The therapeutic efficacy of Nateglinide can be increased when used in combination with Clorexolone. |
| Pentamidine | The therapeutic efficacy of Pentamidine can be increased when used in combination with Clorexolone. |
| Mifepristone | The therapeutic efficacy of Mifepristone can be increased when used in combination with Clorexolone. |
| Tolazamide | The therapeutic efficacy of Tolazamide can be increased when used in combination with Clorexolone. |
| Repaglinide | The therapeutic efficacy of Repaglinide can be increased when used in combination with Clorexolone. |
| Phenformin | The therapeutic efficacy of Phenformin can be increased when used in combination with Clorexolone. |
| Sulfamethoxazole | The therapeutic efficacy of Sulfamethoxazole can be increased when used in combination with Clorexolone. |
| Glyburide | The therapeutic efficacy of Glyburide can be increased when used in combination with Clorexolone. |
| Glipizide | The therapeutic efficacy of Glipizide can be increased when used in combination with Clorexolone. |
| Gliclazide | The therapeutic efficacy of Gliclazide can be increased when used in combination with Clorexolone. |
| Tolbutamide | The therapeutic efficacy of Tolbutamide can be increased when used in combination with Clorexolone. |
| Pioglitazone | The therapeutic efficacy of Pioglitazone can be increased when used in combination with Clorexolone. |